Factors affecting A1C in non-diabetic individuals: Review and meta-analysis

Clinica Chimica Acta

Volumn 445, Issue , 2015, Pages 107-114

  Cavagnolli, Gabriela ^a   Pimentel, Ana Laura ^a   Freitas, Priscila Aparecida Correa ^a   Gross, Jorge Luiz ^a,b   Camargo, Joíza Lins ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anemia; Glycated hemoglobin; Meta analysis; Uremia; Variant hemoglobin

Indexed keywords

HEMOGLOBIN A1C; HEMOGLOBIN S; HEMOGLOBIN VARIANT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HEMOGLOBIN AS;

DIABETES MELLITUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; PRIORITY JOURNAL; REVIEW; SICKLE CELL TRAIT; SYSTEMATIC REVIEW; UREMIA; ADULT; ANEMIA, IRON-DEFICIENCY; FEMALE; MALE; META ANALYSIS; METABOLISM; REGRESSION ANALYSIS;

ADULT; ANEMIA, IRON-DEFICIENCY; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBIN, SICKLE; HUMANS; MALE; REGRESSION ANALYSIS; UREMIA;

EID: 84929428288     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.03.024     Document Type: Review

References (50)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus-position statement. Diabetes Care 2014, 37:S81-S90.
2. WHO Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated Report of a WHO Consultation 2011, World Health Organization, Geneva.
3. Nathan D.M., Singer D.E., Hurxthal K., Goodson J.D. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984, 310:341-346.
4. DCCT - The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-851. U.K. Prospective Diabetes Study (UKPDS) Group.
6. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation 2006, World Health Organization, Geneva.
7. Little R.R., Rohlfing C.L. The long and winding road to optimal HbA1c measurement. Clin Chim Acta 2013, 418:63-71.
8. Hoelzel W., Weykamp C., Jeppsson J.O., et al. IFCC Reference System for measurement of hemoglobin A1c in human blood and the National Standardization Schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004, 50:166-174.
9. American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabetes Care 2007, 30:2399-2400.
10. Little R.R., Sacks D.B. HbA1c: how do we measure it and what does it mean?. Curr Opin Endocrinol Diabetes Obes 2009, 16:113-118.
11. Sacks D.B., Arnold M., Bakris G.L., et al. Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57(6):793-798.
12. Little R.R., Roberts W. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol 2009, 3(3):446-451.
13. Camargo J.L., Gross J.L. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method. J Clin Pathol 2004, 57:346-349.
14. Dagogo-Jack S. Pitfalls in the use of HbA1(c) as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol 2010, 6:589-593.
15. Ziemer D.C., Kolm P., Weintraub W.S., et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010, 152:770-777.
16. Selvin E., Steffes M.W., Ballantyne C.M., Hoogeveen R.C., Coresh J., Brancati F.L. Racial differences in glycemic markers: a cross-sectional analysis of community based data. Ann Intern Med 2011, 154:303-309.
17. Kirk J.K., D'Agostino R.B., Bell R.A., et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006, 29(9):2130-2136.
18. Koga M., Morita S., Saito H., Mukai M. KasayamaS. Association of erythrocyte indices with glycated haemoglobin in premenopausal women. Diabet Med 2007, 24:843-847.
19. Coban E., Ozdogan M., Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004, 112:126-128.
20. El-Agouza I., Abu Shohla A., Sirdah M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol 2002, 24:285-289.
21. Ford E.S., Cowie C.C., Li C., Handelsman Y., Bloomgarden Z.T. Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US. J Diabetes 2011, 3:67-73.
22. Kim C., Bullard K.M., Herman W.H., Beckles G.L. Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010, 33:780-785.
23. Little R.R., Vesper H., Rohlfing C.L., Ospina M. Safar- Pour S, Roberts WL. Validation by a mass spectrometric reference method of use of boronate affinity chromatography to measure glycohemoglobi in the presence of hemoglobin S and C traits. Clin Chem 2005, 51:264-265.
24. Bry L., Chen P.C., Sacks D.B. Effects of hemoglobin variants and chemically modified derivates on assay for glycohemoglobin. Clin Chem 2001, 47:153-163.
25. Little R.R., Rohlfing C.R., Hanson S., et al. Effects of hemoglobin E and D traits on glycated hemoglobin (HbA1c) measurements by twenty-three methods. Clin Chem 2008, 54:1277-1282.
26. Mongia S.K., Little R.R., Rohlfing C.L., et al. Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays. Am J Clin Pathol 2008, 130(1):136-140.
27. Roberts W.L., Safar-Pour S., De B.K., Rohlfing C.L., Weykamp C.W., Little R.R. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 2005, 51(4):776-778.
28. Goujon R., Thivolet C. Glycation of hemoglobin C in the heterozygous state in diabetic patients. Diabetes Care 1994, 17(3):247.
29. Lee B.S., Jayathilaka G.D., Huang J.S., Vida L.N., Honig G.R., Gupta S. Analyses of in vitro nonenzymatic glycation of normal and variant hemoglobins by MALDI-TOF mass spectrometry. J Biomol Tech 2011, 22(3):90-94.
30. Lamb E., Dawnay A. Glycated haemoglobin measurement in uraemic patients. Ann Clin Biochem 1992, 29:118-120.
31. Ansari A., Thomas S., Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis 2003, 41(3):523-531.
32. Szymezak J., Lavalard E., Martin M., Leroy N., Gillery P. Carbamylated hemoglobin remains a critical issue in HbA1c measurements. Clin Chem Lab Med 2009, 47:612-613.
33. Chachou A., Randoux C., Millart H., Chanard J., Gillery P. Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods. Clin Chem Lab Med 2000, 38:321-326.
34. Higgins J.P.T., Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011, [Available at: http://www.cochrane-handbook.org; accessed 12 August 2014].
35. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
36. Wells G.A., Shea B., O'Connell D., et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in metaanalysis Available at:, [accessed 12 August 2014]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
37. Christenson R.H., Snyder S.R., Shaw C.S., et al. Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement. Clin Chem 2011, 57(6):816-825.
38. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
39. Il Son, Rhee S.Y., Woo J.T., et al. Hemoglobin a1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J 2013, 37(5):343-348.
40. Al-Fadhli S.M., Ahmad A.A., Al-Jafar H.A. Effect of sickle cell trait and B-thalassemia minor on determinations of HbA1c by an immunoassay method. Saudi Med J 2001, 22(8):686-689.
41. Rotimi A.N., Yu S.S., Ricks M., et al. Sickle cell trait leads to under diagnosis of glucose intolerance by A1c. Diabetes 2012, 61(Suppl. 1):A214.
42. Boukhrissi F.E., Balouch H., Bamou Y. Evaluation of hemoglobin A1c measurement on the analyzer Cobas® c311. Immuno-analyse et biol spécialisée 2012, 27:28-32.
43. Haliassos A., Drakopoulos I., Katritsis D., Chiotinis N., Korovesis S., Makris K. Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants. Clin Chem Lab Med 2006, 44:223-227.
44. Renacco E., Saunier V., Gras C., Portugal H. Comparaison de cinq automates pour le dosage de l'h moglobine glyquée. Immunoal Biol Spéc 2000, 15:366-372.
45. Lee K.F., Szeto Y.T., Benzie I.F. Glycohaemoglobin measurement: methodological differences in relation to interference by urea. Acta Diabetol 2002, 39(1):35-39.
46. Christy A.L., Manjrekar P., Babu RP M.S.R., Hegde A. Elevation of HbA1C in non-diabetic hypothyroid individuals: is anaemia the connecting link?-a preliminary study. J Clin Diagn Res 2013, 7(11):2442-2444.
47. Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med 2013, 33(6):393-400.
48. Little R.R., Rohlfing C.L. Analytical goals for HbA1c: are HbA1c results good enough for optimal use?. J Diabetes 2011, 3(1):3-6.
49. Little R.R., Rohlfing C.L., Tennill A.L., et al. Measurement of Hba(1C) in patients with chronic renal failure. Clin Chim Acta 2013, 418:73-76.
50. Li Q., Ju Y., Jin T., et al. Haemoglobin A1c measurement in patients with chronic kidney disease. Clin Biochem 2014, 47(6):481-484.